Literature DB >> 9103733

Effectiveness of psychological and pharmacological treatments for obsessive-compulsive disorder: a quantitative review.

J S Abramowitz1.   

Abstract

Quantitative review of the controlled treatment outcome literature for obsessive-compulsive disorder (OCD) showed that exposure with response prevention was highly effective in reducing OCD symptoms. Cognitive approaches were also found to be at least as effective as exposure procedures. It appears that both cognitive and exposure interventions involve some overlapping procedures and capitalize on similar mechanisms of change. Serotonergic medication, particularly clomipramine, also substantially reduced OCD symptoms. However, clomipramine may not be particularly superior to other serotonergic medication. The relationship between side effects and effect size in medication trials was explored.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9103733     DOI: 10.1037//0022-006x.65.1.44

Source DB:  PubMed          Journal:  J Consult Clin Psychol        ISSN: 0022-006X


  41 in total

Review 1.  Should an obsessive-compulsive spectrum grouping of disorders be included in DSM-V?

Authors:  Katharine A Phillips; Dan J Stein; Scott L Rauch; Eric Hollander; Brian A Fallon; Arthur Barsky; Naomi Fineberg; David Mataix-Cols; Ygor Arzeno Ferrão; Sanjaya Saxena; Sabine Wilhelm; Megan M Kelly; Lee Anna Clark; Anthony Pinto; O Joseph Bienvenu; Joanne Farrow; James Leckman
Journal:  Depress Anxiety       Date:  2010-06       Impact factor: 6.505

2.  Acceptance in behavior therapy: Understanding the process of change.

Authors:  J V Cordova
Journal:  Behav Anal       Date:  2001

Review 3.  Obsessive compulsive disorder.

Authors:  G Mustafa Soomro
Journal:  BMJ Clin Evid       Date:  2012-01-18

4.  Modular Cognitive Therapy for Obsessive-Compulsive Disorder: A Wait-List Controlled Trial.

Authors:  Sabine Wilhelm; Gail Steketee; Jeanne M Fama; Ulrike Buhlmann; Bethany A Teachman; Elana Golan
Journal:  J Cogn Psychother       Date:  2009

5.  Topiramate augmentation in a patient with obsessive-compulsive disorder.

Authors:  Michael Van Ameringen; Beth Patterson
Journal:  J Psychiatry Neurosci       Date:  2015-09       Impact factor: 6.186

Review 6.  Components of Cognitive Behavioral Therapy Related to Outcome in Childhood Anxiety Disorders.

Authors:  Chelsea M Ale; Denis M McCarthy; Lilianne M Rothschild; Stephen P H Whiteside
Journal:  Clin Child Fam Psychol Rev       Date:  2015-09

Review 7.  Systematic Review and Meta-Analysis: Early Treatment Responses of Selective Serotonin Reuptake Inhibitors and Clomipramine in Pediatric Obsessive-Compulsive Disorder.

Authors:  Anjali L Varigonda; Ewgeni Jakubovski; Michael H Bloch
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2016-08-04       Impact factor: 8.829

8.  Home-Based Assessment and Treatment of Obsessive-Compulsive Disorder Symptoms to Reduce Unnecessary Emergency Room Usage in an Older Adult.

Authors:  Lewina O Lee; Susan Rouse; Michelle E Mlinac
Journal:  J Cogn Psychother       Date:  2019-03

9.  Exposure and response prevention helps adults with obsessive-compulsive disorder who do not respond to pharmacological augmentation strategies.

Authors:  Carmen P McLean; Laurie J Zandberg; Page E Van Meter; Joseph K Carpenter; Helen Blair Simpson; Edna B Foa
Journal:  J Clin Psychiatry       Date:  2015-12       Impact factor: 4.384

10.  Current trends in drug treatment of obsessive-compulsive disorder.

Authors:  Eric H Decloedt; Dan J Stein
Journal:  Neuropsychiatr Dis Treat       Date:  2010-05-25       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.